Results 11 to 20 of about 79 (64)

Die Bedeutung von CTRP1, CTRP6 und CTRP8 bei der RXFP1-vermittelten Wundheilung der Augenoberfläche [PDF]

open access: yes
Hintergrund und Ziele Die Augenoberfläche ist aufgrund ihrer direkten Exposition zur Umwelt besonders vulnerabel für äußere Verletzungen. Diese können durch physikalische oder che-mische Traumata, Infektionen und Entzündungen verursacht werden und Schmer-
Nicolaus, Hagen Fabian
core   +1 more source

Functional role of C1Q-TNF related peptide 8 (CTRP8)-binding RXFP1 in brain tumors

open access: yes, 2013
Glioblastoma (GB) is the most common and highly aggressive form of primary brain cancer. GB invasiveness and the development of treatment resistance are major clinical challenges. The underlying mechanisms remain poorly understood.
Thanasupawat, Thatchawan
core   +1 more source

Probabilistic Patents

open access: yes, 2018
Economists often assume that a patent gives its owner a well-defined legal right to exclude others from practicing the invention described in the patent. In practice, however, the rights afforded to patent holders are highly uncertain.
Mark Lemley
core   +1 more source

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling. [PDF]

open access: yesBiomedicines, 2023
Schanbacher C   +4 more
europepmc   +1 more source

Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma. [PDF]

open access: yesJ Cancer Metastasis Treat, 2022
Dixit S   +5 more
europepmc   +1 more source

C1q and central nervous system disorders. [PDF]

open access: yesFront Immunol, 2023
Zhang W, Chen Y, Pei H.
europepmc   +1 more source

The peritumoral brain zone in glioblastoma: where we are and where we are going. [PDF]

open access: yesJ Neurosci Res, 2023
Giambra M   +8 more
europepmc   +1 more source

CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication. [PDF]

open access: yesActa Pharmacol Sin, 2023
Zhang H   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy